These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25735901)

  • 1. Reduction in driveline infection rates: Results from the HeartMate II Multicenter Driveline Silicone Skin Interface (SSI) Registry.
    Dean D; Kallel F; Ewald GA; Tatooles A; Sheridan BC; Brewer RJ; Caldeira C; Farrar DJ; Akhter SA;
    J Heart Lung Transplant; 2015 Jun; 34(6):781-9. PubMed ID: 25735901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of INCOR® driveline infection rate with silicone at the driveline exit site.
    Camboni D; Zerdzitzki M; Hirt S; Tandler R; Weyand M; Schmid C
    Interact Cardiovasc Thorac Surg; 2017 Feb; 24(2):222-228. PubMed ID: 27702831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing velour versus silicone interfaces at the driveline exit site of HeartMate II devices: infection rates, histopathology, and ultrastructural aspects.
    McCandless SP; Ledford ID; Mason NO; Alharethi R; Rasmusson BY; Budge D; Stoker SL; Clayson SE; Doty JR; Thomsen GE; Caine WT; Kfoury AG; Reid BB; Miller DV
    Cardiovasc Pathol; 2015; 24(2):71-5. PubMed ID: 25483742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified HeartMate II driveline externalization technique significantly decreases incidence of infection and improves long-term survival.
    Singh A; Russo MJ; Valeroso TB; Anderson AS; Rich JD; Jeevanandam V; Akhter SA
    ASAIO J; 2014; 60(6):613-6. PubMed ID: 25072552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Driveline infections in patients supported with a HeartMate II: incidence, aetiology and outcome.
    Bomholt T; Moser C; Sander K; Boesgaard S; Køber L; Olsen PS; Hansen PB; Mortensen SA; Gustafsson F
    Scand Cardiovasc J; 2011 Oct; 45(5):273-8. PubMed ID: 21539474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and hospital admissions during long-term support with a HeartMate II.
    Rossing K; Jung MH; Sander K; Olsen PS; Hansen PB; Boesgaard S; Gustafsson F
    Scand Cardiovasc J; 2015; 49(6):367-75. PubMed ID: 26400060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.
    John R; Naka Y; Park SJ; Sai-Sudhakar C; Salerno C; Sundareswaran KS; Farrar DJ; Milano CA
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):581-9; discussion 589. PubMed ID: 24418362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of pediatric patients supported by the HeartMate II left ventricular assist device in the United States.
    Cabrera AG; Sundareswaran KS; Samayoa AX; Jeewa A; McKenzie ED; Rossano JW; Farrar DJ; Frazier OH; Morales DL
    J Heart Lung Transplant; 2013 Nov; 32(11):1107-13. PubMed ID: 24002006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Special Treatment and Wound Care of the Driveline Exit Site after Left Ventricular Assist Device Implantation.
    Menon AK; Baranski SK; Unterkofler J; Autschbach R; Moza AK; Goetzenich A; Tewarie L
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):670-4. PubMed ID: 26177225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.
    Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS
    ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
    J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.
    Park SJ; Milano CA; Tatooles AJ; Rogers JG; Adamson RM; Steidley DE; Ewald GA; Sundareswaran KS; Farrar DJ; Slaughter MS;
    Circ Heart Fail; 2012 Mar; 5(2):241-8. PubMed ID: 22282104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Driveline angle is crucial for preventing driveline infection in patients with HeartMate II device.
    Matsumoto Y; Fukushima S; Shimahara Y; Yamashita K; Kawamoto N; Kuroda K; Seguchi O; Yanase M; Fukushima N; Shimizu H; Kobayashi J; Fujita T
    J Artif Organs; 2019 Mar; 22(1):37-43. PubMed ID: 30298341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of modular cable exchange in HeartMate 3 patients versus conventional driveline repair in HeartMate II patients.
    Merzah AS; Hanke JS; Li T; Saad Merzah FA; Gabriel M; Derda AA; Homann K; Haverich A; Schmitto JD; Dogan G
    Artif Organs; 2023 Feb; 47(2):380-386. PubMed ID: 36148849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support.
    Urban M; Pirk J; Szarszoi O; Besik J; Netuka I
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):372-8. PubMed ID: 25487235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary.
    Stulak JM; Maltais S; Cowger J; Joyce LD; Daly RC; Park SJ; Aaronson KD; Pagani FD
    ASAIO J; 2013; 59(6):570-4. PubMed ID: 24172262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.